{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:13:07Z","timestamp":1707523987483},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,2]]},"DOI":"10.7759\/cureus.44566","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T13:50:20Z","timestamp":1693662620000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Angioimmunoblastic T-Cell Lymphoma and the Difficulties of Diagnosis"],"prefix":"10.7759","author":[{"given":"Michelle","family":"Koifman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqqas","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amith","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092585","article-title":"No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases","volume":"9","author":"Xu B","year":"2014","unstructured":"Xu B, Liu P. No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases. PLoS One. 2014, 9:e92585. 10.1371\/journal.pone.0092585","journal-title":"PLoS One"},{"key":"ref2","article-title":"Peripheral T-cell lymphoma","author":"Rangoonwala HI","year":"2022","unstructured":"Rangoonwala HI, Cascella M. Peripheral T-cell lymphoma. StatPearls. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqab090","article-title":"How I diagnose angioimmunoblastic T-cell lymphoma","volume":"156","author":"Xie Y","year":"2021","unstructured":"Xie Y, Jaffe ES. How I diagnose angioimmunoblastic T-cell lymphoma. Am J Clin Pathol. 2021, 156:1-14. 10.1093\/ajcp\/aqab090","journal-title":"Am J Clin Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016932","article-title":"Angioimmunoblastic T-cell lymphoma mimicking drug fever and infectious etiology after a thyroidectomy: A case report","volume":"98","author":"Han P","year":"2019","unstructured":"Han P, Yang L, Yan W, Tian D. Angioimmunoblastic T-cell lymphoma mimicking drug fever and infectious etiology after a thyroidectomy: A case report. Medicine (Baltimore). 2019, 98:e16932. 10.1097\/MD.0000000000016932","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06577.x","article-title":"Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma","volume":"137","author":"Grogg KL","year":"2007","unstructured":"Grogg KL, Morice WG, Macon WR. Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma. Br J Haematol. 2007, 137:416-22. 10.1111\/j.1365-2141.2007.06577.x","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4367","article-title":"Not your typical morbilliform rash: Angioimmunoblastic T-cell lymphoma","volume":"9","author":"Bao W","year":"2021","unstructured":"Bao W, Buchanan KL, Davis LS. Not your typical morbilliform rash: Angioimmunoblastic T-cell lymphoma. Clin Case Rep. 2021, 9:04367. 10.1002\/ccr3.4367","journal-title":"Clin Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v11.i6.405","article-title":"Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia: A case report","volume":"11","author":"Kawahigashi T","year":"2020","unstructured":"Kawahigashi T, Kitagawa I, Tanaka E. Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia: A case report. World J Clin Oncol. 2020, 11:405-11. 10.5306\/wjco.v11.i6.405","journal-title":"World J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08329.x","article-title":"Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP\/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95","volume":"151","author":"Simon A","year":"2010","unstructured":"Simon A, Peoch M, Casassus P, et al.. Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP\/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. Br J Haematol. 2010, 151:159-66. 10.1111\/j.1365-2141.2010.08329.x","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.2719","article-title":"Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01","volume":"30","author":"d'Amore F","year":"2012","unstructured":"d'Amore F, Relander T, Lauritzsen GF, et al.. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012, 30:3093-9. 10.1200\/JCO.2011.40.2719","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.816700","article-title":"Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)","volume":"55","author":"Ganjoo K","year":"2014","unstructured":"Ganjoo K, Hong F, Horning SJ, et al.. Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). Leuk Lymphoma. 2014, 55:768-72. 10.3109\/10428194.2013.816700","journal-title":"Leuk Lymphoma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.623256","article-title":"Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial","volume":"53","author":"Advani RH","year":"2012","unstructured":"Advani RH, Hong F, Horning SJ, et al.. Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial. Leuk Lymphoma. 2012, 53:718-20. 10.3109\/10428194.2011.623256","journal-title":"Leuk Lymphoma"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074641","article-title":"Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial","volume":"110","author":"Gallamini A","year":"2007","unstructured":"Gallamini A, Zaja F, Patti C, et al.. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood. 2007, 110:2316-23. 10.1182\/blood-2007-02-074641","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2015.11.008","article-title":"Alemtuzumab and CHOP chemotherapy for the treatment of aggressive histology peripheral T cell lymphomas: a multi-center phase I study","volume":"16","author":"Buckstein R","year":"2016","unstructured":"Buckstein R, Fraser G, Cheung M, et al.. Alemtuzumab and CHOP chemotherapy for the treatment of aggressive histology peripheral T cell lymphomas: a multi-center phase I study. Clin Lymphoma Myeloma Leuk. 2016, 16:18-28.e4. 10.1016\/j.clml.2015.11.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01759-8","article-title":"Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study","volume":"18","author":"Wyss K","year":"2020","unstructured":"Wyss K, Granath F, W\u00e5ngdahl A, Dj\u00e4rv T, Fored M, Naucler P, F\u00e4rnert A. Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study. BMC Med. 2020, 18:296. 10.1186\/s12916-020-01759-8","journal-title":"BMC Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005909","article-title":"Acute malaria induces  PD1+CTLA4+ effector T cells with cell-extrinsic suppressor function","volume":"12","author":"Mackroth MS","year":"2016","unstructured":"Mackroth MS, Abel A, Steeg C, Schulze Zur Wiesch J, Jacobs T. Acute malaria induces  PD1+CTLA4+ effector T cells with cell-extrinsic suppressor function. PLoS Pathog. 2016, 12:e1005909. 10.1371\/journal.ppat.1005909","journal-title":"PLoS Pathog"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.584261","article-title":"Increased serum level of interleukin-10 predicts poor survival and early recurrence in patients with peripheral T-cell lymphomas","volume":"10","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Zheng Y, Shou L, et al.. Increased serum level of interleukin-10 predicts poor survival and early recurrence in patients with peripheral T-cell lymphomas. Front Oncol. 2020, 10:584261. 10.3389\/fonc.2020.584261","journal-title":"Front Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19301","article-title":"Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma","volume":"8","author":"Ham JS","year":"2017","unstructured":"Ham JS, Park HY, Ryu KJ, Ko YH, Kim WS, Kim SJ. Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma. Oncotarget. 2017, 8:76231-40. 10.18632\/oncotarget.19301","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/156610-a-case-of-angioimmunoblastic-t-cell-lymphoma-and-the-difficulties-of-diagnosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:34Z","timestamp":1707508654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/156610-a-case-of-angioimmunoblastic-t-cell-lymphoma-and-the-difficulties-of-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.44566","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,2]]}}}